Lawsuits Filed Over Stomach Problems Linked to Ozempic & Similar Drugs

Patients who have been prescribed Ozempic, Mounjaro, Wegovy, or other comparable medications for diabetes or obesity and have experienced gastroparesis or other gastrointestinal complications may be eligible to pursue legal action and seek compensation for their health problems.

To start your claim today, contact the lawyers at Hissey Mulderig & Friend by calling our offices toll-free at 1-866-806-8117, or by filling out our free claims submission form located on the right side of this page.

Ozempic, Other Diabetes-Weight Loss Drugs Linked to Gastroparesis, Other Illnesses

Ozempic, a medication containing semaglutide, falls under the category of GLP-1 receptor agonists, which were initially sanctioned by the FDA for diabetes treatment but are frequently used off-label by physicians to aid in weight management. Among the other drugs in this class are Mounjaro (tirzepatide), Rybelsus (semiglutide), Saxenda (liraglutide), Trulicity (dulaglutide), and Wegovy (semaglutide).

As the utilization of Ozempic and similar medications expanded to assist individuals battling obesity, reports emerged from both doctors and patients regarding severe stomach issues experienced by those undergoing treatment.

A subset of patients administered Ozempic, Mounjaro, and other GLP-1 receptor agonists have developed gastroparesis, a critical gastrointestinal ailment characterized by weakened nerves and muscles in the stomach, leading to digestive complications.

Additional gastrointestinal issues associated with Ozempic and analogous drugs include stomach paralysis (“frozen stomach”), bowel obstructions, ileus (intestinal inability to expel food or waste), and intestinal blockages.

First Ozempic, Mounjaro Lawsuit Filed in 2023

In the autumn of 2023, the initial legal action against the producers of Ozempic and Mounjaro was initiated by a woman from Louisiana who encountered severe gastrointestinal side effects following the consumption of both drugs to manage her type 2 diabetes.

Janice Bjorklund, as per her legal claim, asserts that after several months of taking Ozempic and Mounjaro, she started to display symptoms of severe gastrointestinal issues, such as vomiting and abdominal pain.

Bjorklund claims that she was eventually admitted to the hospital due to her illness, and her physicians prescribed medications to alleviate her gastrointestinal symptoms. Her lawsuit contends that Novo Nordisk and Eli Lilly, the manufacturers of Ozempic and Mounjaro, neglected to adequately advise doctors and patients about the potential risk of severe gastrointestinal issues that could arise from the use of these medications.

Numerous other lawsuits have also been filed against the producers of Ozempic and Mounjaro by other individuals who developed gastroparesis or other side effects after utilizing these drugs for diabetes and weight loss management.

Legal representatives involved in this litigation anticipate that up to 10,000 lawsuits could eventually be filed by patients who suffered from serious gastrointestinal disorders due to Ozempic, Mounjaro, or other medications belonging to this drug category.

Start Your Ozempic Claim Today

If you or a family member have taken medications like Ozempic, Mounjaro, Wegovy, Rybelsus, Saxenda, or Trulicity for the purpose of weight loss or managing diabetes, and have received a diagnosis of gastroparesis, stomach paralysis, or other gastrointestinal complications, you could potentially qualify to pursue legal action and seek compensation for the harm caused.

To start the process of filing your claim today, contact the law firm of Hissey Mulderig & Friend for a free legal consultation from our attorney. You can contact us by calling toll-free at 1-866-806-8117, or by filling out our free claims submission form located at the top of this page.

About the Author: Hissey, Mulderig & Friend